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Abstract
Background: Complications from type 2 diabetes mellitus can be prevented when patients perform health behaviors such as
vigorous exercise and glucose-regulated diet. The use of smartphones for tracking such behaviors has demonstrated success in
type 2 diabetes management while generating repositories of analyzable digital data, which, when better understood, may help
improve care. Data mining methods were used in this study to better understand self-monitoring patterns using smartphone
tracking software.
Objective: Associations were evaluated between the smartphone monitoring of health behaviors and HbA1c reductions in a
patient subsample with type 2 diabetes who demonstrated clinically significant benefits after participation in a randomized
controlled trial.
Methods: A priori association-rule algorithms, implemented in the C language, were applied to app-discretized use data involving
three primary health behavior trackers (exercise, diet, and glucose monitoring) from 29 participants who achieved clinically
significant HbA1c reductions. Use was evaluated in relation to improved HbA1c outcomes.
Results: Analyses indicated that nearly a third (9/29, 31%) of participants used a single tracker, half (14/29, 48%) used two
primary trackers, and the remainder (6/29, 21%) of the participants used three primary trackers. Decreases in HbA1c were observed
across all groups (0.97-1.95%), but clinically significant reductions were more likely with use of one or two trackers rather than
use of three trackers (OR 0.18, P=.04).
Conclusions: Data mining techniques can reveal relevant coherent behavior patterns useful in guiding future intervention
structure. It appears that focusing on using one or two trackers, in a symbolic function, was more effective (in this sample) than
regular use of all three trackers.
(JMIR Diabetes 2016;1(1):e1)   doi:10.2196/diabetes.4506
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Introduction
Diabetes is a cluster of metabolic conditions characterized by
dysglycemia from defects in insulin secretion and/or unhealthy
behaviors that cause debilitating complications and death [1,2].
In 2013, an estimated 8.3% of the global population lived with
diabetes and more than US $612 billion was spent on treatment
[3]. A type 2 diabetes (T2DM) diagnosis, affecting 90-95% of
people with diabetes, largely results from genetic predisposition,
excess body weight, physical inactivity, and poor diet [1].
Additional studies demonstrate that lower socioeconomic status
(SES) populations are at greater risk for developing diabetes
[4,5] and often demonstrate poorer disease management,
resulting in more frequent (and more expensive) complications
and hospitalizations [5].
There is consensus among researchers and clinical professionals
that glucose self-monitoring, exercise, and diet-related health
behaviors are important in effective T2DM management and
well-regulated serum glucose levels [6]. Monitoring health
behaviors (ie, exercise, healthy diet, glucose monitoring) may
be important in improving glucose control [6]. Mobile tracking
technologies can help patients adopt and sustain
self-management behaviors and can help health professionals
provide better monitoring and support. However, there are
challenges in determining the optimal design of self-tracking
tools and their optimal use with respect to frequency and
duration.
Data mining (DM) refers to analytic approaches useful in
detecting coherent patterns in large and complex datasets [7].
The applications of DM methods in analyses of diabetes-related
health behaviors are continually being improved, especially in
the selection of analytic frameworks that capture key data with
sufficient explanatory power [8].
As utilization of electronic health records increases in health
care, DM becomes more relevant [9] to chronic disease
prevention and management [8]. A recent study utilized
descriptive DM algorithms to analyze a dataset with 450
attributes to identify a “short list” of the behavioral correlates
of depressive disorder [10]. This study exemplifies use of DM
in datasets lacking the uniformity needed for more conventional
analyses [11]. DM can help integrate variables of multiple types
(eg, diet, exercise, blood pressure, SES, income, geographic
location) in better understanding factors affecting diabetes
incidence, prevalence, and management [7].
In another diabetes study, DM algorithms were used to construct
a model that predicted short-term changes in blood glucose [12]
exemplifying how DM can help identify risk factors for
hypoglycemia [13]. Several studies found that information
collected on meals, insulin therapy, and physical activity
improved the prediction of blood glucose levels [12-14].
Applying DM analyses to self-monitoring data could help
identify key indicators in the prevention of life-threatening
hypoglycemic events [15]. DM applied to primary medical data
could point to useful methods for initiating and maintaining
effective T2DM treatment, leading to better resource allocation
and treatment personalization [16,17].
Health coaching is a promising clinical role that stimulates and
supports health behavior change in patients with varying SES,
health problems and diagnosed chronic diseases. When
connected with 24 hour/day/7 day/week mobile phone-based
counseling, health coaching is associated with benefits for
individuals affected by uncontrolled T2DM [18-20] and chronic
obstructive pulmonary disease [17].
Objective
Our primary objective was to evaluate associations between the
mobile phone monitoring of health behaviors, within a
randomized controlled trial (RCT), and clinically significant
reductions in glycated hemoglobin (HbA1c).
Methods
The RCT protocol was reviewed and approved by the York
University research ethics board (Certificate #2012-033), and
all patients provided written, informed consent to participate.
The RCT assessed T2DM patients (N=97) assisted by personal
health coaches trained in behavior-change theories, practices,
and counseling methods (see Figure 1). At baseline, all patients
had poor glucose regulation as indicated by glycated hemoglobin
(HbA1c) ≥7.3%. In the mobile phone–assisted intervention arm,
participants (n=48) were provided a smartphone (Samsung
Galaxy Ace 2) with data service and pre-installed health tracking
software (NexJ Systems Inc., Connected Wellness Platform
[CWP]) enabling the detailed monitoring of two behaviors
(exercise and diet) and a risk-related outcome (blood glucose)
throughout a 24-week intervention. Health coaches helped
patients use the mobile phone software in ways that best fit their
daily routines.
CWP use data were extracted from NexJ Systems servers upon
trial completion and compiled into .csv files stored on
password-protected portable drives. Study participant IDs were
matched with software user IDs, as data were anonymized and
prepared for analyses.
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Figure 1. Flowchart of enrollment.
Data Analysis
Association Rule Algorithms
To discover useful relationships between self-tracker use and
HbA1c outcomes, we employed association-rule algorithms
software to find coherent relationships in transactions
represented by sets of items, termed “frequent item sets.” For
example, when customer A buys bread and cheese, and customer
B buys bread, cheese and burgers, bread and cheese appear
frequently on both shopping lists. Therefore, bread and cheese
are associated and they qualify as a frequent item set [bread,
cheese]. Support is a term reflecting the measurement of
association frequency, as defined by the percentage of
observations to which the item sets belong. In our study, support
was defined as the number of times an attribute value (such as
a1c 6 month diff=1.1) or a set of attribute values (such as
glucose_count=200 and food_count=150) appear in participant
data, divided by the total number of participants, expressed in
a percentage (ie, multiplied by 100).
We used association rule algorithms to identify all common
attributes in participants. The support threshold was fixed at a
minimum of 5%, such that item sets were generated that
occurred in at least 5% of the sample. We used the a priori
association rule algorithm implemented by C language for the
Unix/Linux environment.
Attribute Selection
Among the 97 T2DM study completers, the present analysis
considers patients in the experimental group (n=48). As our
objective was to evaluate associations between the use frequency
of different trackers in the CWP in relation to HbA1c outcomes,
we selected the change in HbA1c over 24 weeks
(a1c6month_diff) and 4 software uses as the attributes for the
association rule algorithm. These attributes were use frequency
of the blood glucose tracker (glucose_count), use frequency of
the food tracker (food_count), use frequency of the exercise
tracker (exercise_count), and the total use frequency of all three
trackers (generic_count).
Discretization
We proceeded to discretize the attributes to implement the
association rule algorithm. For the four tracker attributes
(glucose_count, food_count, exercise_count, and generic_count),
data were discretized into categories relevant to typical use
during a standard week, with numerical criteria selected to
reflect significant adoption levels by patients (see Table 1).
Discretization was compiled differently per tracker to align with
expected and actual adoption rates per tracked behavior (or
outcome). For example, glucose management in T2DM includes
self-monitoring of serum-glucose via finger prick, recommended
several times daily for poorly managed patients, and less often
if there is better gluco-regulation. Use of the blood glucose
tracker was discretized based on frequencies of 1-4.9 uses per
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week, 5-7.9 uses per week, 8-13.9 uses per week, and 14-21.9
uses per week. For food tracking, a similar discretization pattern
was used. Since use frequency fluctuated, discretization was
calculated as up to once per week, 1-3.9 uses per week, 4-6.9
uses per week, 7-13.9 uses per week (1 to <2/day), 14-20.9 uses
per week (2 to <3/day), and 21+ per week (3+/day). Since the
exercise tracker was the least frequently used, discretization
rules were adjusted to once every other week, 0.5-0.9 uses per
week, 1-1.9 uses per week, 2-2.9 uses per week, 3-3.9 uses per
week, and 4<6 uses per week. The total use of all trackers was
discretized to once per week, 1-3.9 times per week, 4-6.9 times
per week (0.5-1/day), 7-13.9 times per week (1-2/day), 14-17.9
times per week (2-4/day), 18-34.9 times per week (4-5/day),
and 35-50 times per week (5-7/day).
Table 1. Discretization of tracker use frequency a-d.
MeaningRangeGroupAttribute
Zero0-01Glucose count
Up to once per week5-242
1-4.9 times/week24-1203
5-7.9 times/week120-1924
8-13.9 times/week192-3365
14-21.9 times/week336-5206
Zero0-01Exercise count
Minimal (>0-4)0-52
Once every other week5-123
0.5-0.9 time/week12-244
1-1.9 times/week24-485
2-2.9 times/week48-726
3-3.9 times/week72-967
4-6 times/week96-1508
Zero0-01Food count
>0-5 over 6 months1-52
Up to 1 time/week5-243
1-3.9 times/week24-964
4-6.9 times/week (1/day)96-1685
7-13.9 times/week (1-1.9/day)168-3366
14-20.9 times/week (2-2.9/day)336-5047
21+ times/week (3+/day)504-7208
Zero0-01Generic count
1 time/week0-242
1-3.9 times/week24-963
4-6.9 times/week (0.5-1/day)96-1684
7-13.9 times/week (1-2/day)168-3365
14-17.9 times/ week (2-4/day)336-6726
18-34.9 times/ week (4-5/day)672-8407
35-50 times/week (5-7/day)840-12008
aAttribute=type of tracker used.
bGroup=discretization group.
cRange=frequencies of use for allocation to group.
dMeaning=frequency of use in terms of use per week/day.
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Preprocessing for HbA1c Attribute
For the a1c6month_diff attribute, conceived of as the most
important attribute in investigating the desired associations, we
preserved its original value to an optimal degree. Therefore, we
did not discretize this attribute but created an extension of
attributes based on the a1c6month_diff attribute. We obtained
a set of all possible values for a1c6month_diff attribute (a), such
as {-1.4, -0.8, -0.5, -0.3, -0.1, 0, 0.1, 0.2, 0.5, an}. For patients
with an a1c6month_diff value of a1 through to an, we created
the following new attributes: a1c6_at_least_-1.4,
a1c6_at_least_-0.8, a1c6_at_least_-0.5, ..., a1c6_at_least_n.
Accordingly, the patient with the lowest reduction value was
associated with only one attribute value (of this kind) while the
patient with the highest reduction was associated with all the
attribute values established.
Postprocessing of Associations
The above pre-processing approaches produced redundancies
in the input data for the association rule algorithm. Therefore,
we applied three approaches to post-processing after the
associations were generated. First, if a frequent item set
contained only a1c6_at_least_an attribute values, where an is a
float number (from a1 to an), we removed such item sets (for
example, a1c6_at_least_0.4 a1c6_at_least_0.2 and
a1c6_at_least_-0.3 a1c6_at_least_-0.8 a1c6_at_least_-1.4).
The preceding two frequent item sets were thus removed because
the extra a1c6_at_least values were added by the pre-processing
approach were not relevant unless generated together with the
other attributes.
Second, for a frequent item set, if a1c6_at_least_an the attribute
values that appeared multiple times were removed except the
a1c6_at_least_an where n is the largest value among the “a1c6”
values, (for example, glucose_120 a1c6_at_least_0.5
a1c6_at_least_0.3).
In this frequent item set, the a1c6_at_least attribute occurred
twice. However, when a reduction value for “a1c6” of at least
0.5 exists, by default, the reduction value of 0.3 must exist.
Therefore, a1c6_at_least_0.3 was a redundant attribute value
and was therefore removed. The above frequent item set
becomes the following after post-processing: glucose_120
a1c6_at_least_0.5.
Third, after considering the above two situations, redundant
item sets existed in the result. For example, glucose_120
a1c6_at_least_0.7 a1c6_at_least_0.4 and glucose_120
a1c6_at_least_0.7 a1c6_at_least_0.1. These two frequent item
sets both contained redundant “a1c6_at_least” attribute values.
After considering the second situation, these two frequent item
sets became glucose_120 a1c6_at_least_0.7 and glucose_120
a1c6_at_least_0.7. Since they were identical and their support
values were identical, we removed one of them.
Pre- and postprocessing were implemented by Python using the
Linux environment. Attribute selection and categorization were
used to determine how system use was associated with change
in HbA1c per participant. A minimum clinically significant
change approach was used to determine what proportion of
participants demonstrated 0.5% (5.5 mmol/mol) or greater
reductions of HbA1c and used trackers at variable levels of
intensity [21]. Therefore, patient data were extracted only with
associations containing the attribute-value pair a1c_0.5,
representing changes in HbA1c values that were 0.5% or above,
which was true for 29 participants.
Last, a Fisher’s exact test for count data was applied to
determine the statistical relationship between use of all three
trackers, use of one or two trackers, and HbA1c reductions. For
this test, the 10 intervention participants who used the software
but did not have a clinically significant reduction in HbA1c
were used as a comparison group. Results were considered
significant at the P=.05 level.
Results
Usage Data
In total, 48 intervention patients completed the 24-week trial.
Only 39 patients used the CWP software to track health
behaviors. Of this software software-user sample, 29 reduced
their HbA1c measure by clinically significant levels at trial
conclusion, defined as 0.5% (5.5 mmol/mol) or greater (see
Figure 2). Demographic and baseline characteristics of the
clinically significant HbA1c reduced-users are provided in Table
2 and compared with the full intervention sample. While
multiple health trackers were available in the CWP, most
participants used one or a combination of two-to-three specific
trackers (ie, between (1) glucose monitoring, (2) exercise
tracking, and (3) food tracking) (see Figures 3-5). These trackers
reflect the behaviors often considered relevant in diabetes
management and therefore the trackers often recommended by
health coaches for patients use. Of the 29 clinically significant
HbA1c reduced-user group (selected as a subpopulation of
interest [SOI]) (HbA1c reduction ≥0.5%), 2 singularly used the
food tracker and 7 singularly used the glucose tracker, while no
subjects singularly used the exercise tracker. Meanwhile, 11 of
these subjects used both glucose and exercise trackers, 3 used
both glucose and food trackers, while 0 subjects used both food
and exercise trackers. Last, 6 subjects used all three trackers.
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Table 2. Subject demographics.
Full intervention sample (n=48)SOI
(n=29)
53.1 (26-74) 10.953.4 (26-68) 10.7Age in years, mean (range) SD
HbA1c, % (mmol/mol) SD
8.69% (71.5) 1.328.88% (73.6) 1.30Baseline
7.88% (62.6) 1.177.52% (58.7) 0.956 months
0.81% (8.9)1.36% (14.9)Reduction (baseline to 6 months)
Sex, n (%)
17 (35)11 (33)Male
31 (65)18 (66)Female
Education, n (%)
10 (21)5 (17)Less than high school
17 (35)14 (48)High school
11 (23)6 (21)College diploma or vocational training
8 (17)4 (14)University degree
2 (4)0 (0)Did not disclose
Car access, n (%)
19 (40)10 (34)Owns a car
9 (19)8 (28)Has access to car
19 (40)11 (38)No access to car
1 (2)0 (0)Not disclosed
Employment status, n (%)
16 (33)10 (35)Unemployed
3 (6)1 (3)Student
1 (2)0 (0)Part-time
13 (27)8 (28)Full-time
6 (13)3 (10)Retired
6 (13)5 (17)Self-employed
2 (4)2 (7)Work in the home (take care of children)
1 (2)0 (0)Not disclosed
Income in CAD$, n (%)
9 (19)4 (14)0-9999
10 (21)8 (28)10,000-25,000
12 (25)7 (24)25,000-50,000
3 (6)2 (7)50,000-75,000
4 (8)3 (10)75,000-up
10 (21)5 (17)Did not disclose
As seen in Table 3, the HbA1c reductions of subjects who used
single trackers (food-tracker only or glucose-tracker only) did
not significantly differ from each other. More subjects (11/48,
22.9%) used the glucose and exercise tracker in combination
than the glucose and food tracker in combination (3/48, 6.3%),
but there were no significant differences in HbA1c levels in
these subjects. The 6 of 48 subjects (12.5%) who used all three
trackers (glucose/food/exercise) achieved a mean HbA1c
reduction of 1.55%.
The Fisher’s exact test for count data indicated subjects who
used the software (n=39) were more likely to achieve a clinically
significant reduction in HbA1c if they used one or two trackers
than if they used all three trackers (OR 0.18, P=.04) (see Table
4).
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Table 3. Tracker usage pattern.
SDMean reduction of HbA1c, %Users, nMobile phone tracker
1.201.952Food only
1.001.747Glucose only
000Exercise only
0.380.9711Glucose + exercise
0.451.073Glucose + food
000Food + exercise
0.491.556Glucose + food + exercise
Table 4. Fisher’s exact test for count data on three trackers versus lessa.
Did not achieve clinical HbA1c reduc-
tion (<0.5%)
Achieved clinical HbA1c reduction
(≥0.5%)
66All 3 trackers
423<3 trackers
aOR 0.18 and P=.04.
Figure 2. Breakdown of smartphone usage group.
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Figure 3. Food tracker.
Figure 4. Blood glucose tracker.
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Figure 5. Exercise tracker.
Data Mining
The glucose tracker was the most frequently used CWP function.
Altogether, 22.9% (11/48) of subjects tracked their blood
glucose with the software 1-4.9 times per week and had a
clinically significant reduction in HbA1c (>0.5%) (see Table
5) while an additional 22.9% with >0.5% reduction in HbA1c
demonstrated more frequent glucose tracker use (6/48, 12.5%)
and used it 5-7.9 times per week while 10.4% (5/48) used it
8-13.9 times per week.
The food tracking function followed a similar pattern, although
with slightly less frequent use. We found 9/48 (18.8%) of
participants who achieved at least a 0.5% reduction in HbA1c
used the food tracker a minimal amount (one time or less per
week), while 7/48 (14.6%) used the system 1-3.9 times per
week, and 4/48 (8.3%) used the system 4-6.9 times per week
(see Table 6).
The least used tracker (and the only tracker that was never
singularly used) was the exercise tracker, which was used by
7/48 (14.6%) of the intervention participants between 0.5-0.9
times per week (Tables 7 and 8). When it was paired with
glucose tracking, however, every patient who used the exercise
tracker had clinically significant reductions in HbA1c (see
Figure 6).
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Table 5. Glucose tracker use.
Glucose
8-13.9 times/week
Glucose
5-7.9 times/week
Glucose
1-4.9 times/week
HbA1c diff.
nUsers, %nUsers, %nUsers, %
612.5612.51429.20.1
612.5612.51327.10.2
612.5612.512250.3
612.5612.51122.90.4
510.4612.51122.90.5
510.4510.41020.80.6
510.4 8510.4918.80.7
510.4510.4816.70.8
510.4510.4816.70.9
48.3510.4714.61.1
48.3510.41.2
48.3510.41.3
48.348.31.5
Table 6. Food tracker use.
Food 4-6.9x/wkFood 1-3.9x/wkFood up to 1x/wkHbA1c diff.
nUsers, %nUsers, %nUsers, %
48.3816.71020.80.1
48.3816.7918.80.2
48.3714.6918.80.3
48.3714.6918.80.4
48.3714.6918.80.5
48.3612.5816.70.6
48.3510.4816.70.7
48.3510.4816.70.8
48.348.3714.60.9
714.60.11
48.30.12
48.30.13
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Table 7. Exercise tracker use—Part 1.
Exercise 1x every other wkExercise <5x in 6 monthsExercise up to 1x/wkHbA1c diff.
nUsers, %nUsers, %nUsers, %
714.6816.7816.70.1
714.6714.6816.70.2
714.6714.6714.60.3
612.5612.5714.60.4
612.5612.5714.60.5
48.3612.5612.50.6
48.3612.5612.50.7
48.3612.5612.50.8
48.3510.4612.50.9
48.3510.4612.50.11
510.448.30.13
48.30.15
Table 8. Exercise tracker use—Part 2.
Exercise 2-2.9x/wkExercise 1-1.9x/wkExercise 0.5-0.9x/wkHbA1c diff.
nUsers, %nUsers, %nUsers, %
48.348.3714.60.1
48.348.3714.60.2
48.3714.60.3
48.3714.60.4
714.60.5
714.60.6
612.50.7
612.50.8
510.40.9
48.30.11
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Figure 6. Tracker usage group by clinical HbA1c reduction (ÃƒÂ¢Ã¢â‚¬Â°Ã‚Â¥0.5%).
Discussion
Principal Findings
In the emergent field of mobile phone–assisted health coaching,
a recurring question is whether the expense of integrating
mHealth technology justifies the benefits. This highlights the
need to further investigate for whom (which subpopulations)
these technologies are useful and which technologies are most
useful for them. In addressing these questions, this study pilots
a method of investigating RCT participants, focusing on those
who derived clinically significant benefit from participation and
made significant use of the mobile phone software. The study
specifies how much use they engaged in, and the associated
benefits, using the clinically significant reduction in HbA1c
criteria of 0.5% (5.5 mmol/mol) or greater.
By employing attribute categorizations, tracker-use frequencies
were determined per subject in an SOI of significant users who
also derived clinically significant glucose reductions. This
dataset enabled comparison of subjects who used single trackers
versus multiple trackers (two or three trackers). Descriptive
results indicated that in subjects achieving a 0.5% HbA1c
reduction or better, singular use of the glucose and food
monitoring was undertaken, while, in contrast, in the same
group, no singular use of the exercise tracker was undertaken.
In dual-tracker use, glucose and exercise trackers were employed
by more subjects than glucose and food tracking. Interestingly,
food and exercise (as dual) trackers were not used by any of the
subjects who met criteria for 0.5% HbA1c reduction or greater.
Last, all three trackers were used by 12.5% (6/48) of subjects
and were associated with a substantive HbA1c mean reduction
(1.55% or 16.9 mmol/mol).
The Fisher’s exact test for count data indicated that for subjects
who used the software (n=39) and used all three trackers, there
was a significantly lower likelihood of achieving a clinically
significant reduction in HbA1c than for those who used a lesser
number (ie, one or two trackers) (OR 0.18, P=.04). This finding
indicates that it might be advisable for patients with type 2
diabetes to focus on one or two trackers, especially if one tracker
assesses blood glucose levels. From a behavioral perspective,
these data could influence health coaching recommendations
for health behavior tracking.
Limitations
Data mining is often used to process large amounts of data. One
limitation of the pilot application of data mining in this study
was the relatively small user sample size. Nonetheless, the
association rule algorithm technique offers a foundation with
which to study larger datasets of mHealth tracking technologies
as they become available. In terms of diabetes intervention, this
was an RCT of typical size (48 intervention participants) and,
altogether 10,695 uses of the mobile phone app were analyzed
(about 62 uses per month per participant who used the software).
Although future DM studies may address larger datasets, this
pilot demonstrated application in an RCT dataset within which
>10,000 app uses were analyzed (averaging ~1 use per day).
Conclusion
In summary, this study points to a future when the mobile
monitoring of health behaviors will increase and provide digital
signals representing engagement in discrete behaviors and
daily-weekly-monthly outcomes. Whereas previous associations
between counseling and outcomes were difficult to obtain and
often based on retrospective self-report, mobile phone
monitoring offers ongoing records that precisely reflect status
improvements, their stability, and fluctuations (eg, relapsing
patterns). Altogether, with the increasing collection of wearable
data, we may derive a quantifiable perspective on health changes
that instructs the patient and health coach in improving chronic
disease management.
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